Achillion Pharma (ACHN) Reports In-Line Q2 EPS

Achillion Pharma (NASDAQ: ACHN) reported Q2 EPS of ($0.16), in-line with the analyst estimate of ($0.16).

For earnings history and earnings-related data on Achillion Pharma (ACHN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance